News Focus
News Focus
icon url

Investor082

11/13/24 9:39 AM

#731780 RE: ATLnsider #731769

The same lightening speed that you made predictions about L worldwide approvals and reimbursements 3-4 years ago? ;)
icon url

dstock07734

11/13/24 9:53 AM

#731786 RE: ATLnsider #731769

Fantastic suggestion!

After the UK approval, everything concerning DCVax will move lightening speed. Tumor shrinkage will be adopted as primary ending point and it will take months to draw definitive conclusion. Have we seen trials like that often? ABSOLUTELY NO.

BTW, if I am not mistaken, it seems like tumor shrinkage can be used as outcome measure for both DCVax-L and Direct. I can understand it for the Direct. I don't understand it for L. Does this mean they don't need to remove all the tissues surrounding tumors and they just need enough tumor tissues to make the vaccine?
icon url

iclight

11/13/24 10:39 AM

#731829 RE: ATLnsider #731769

The only lightening is of shareholder value. Lightning is what you have a better chance of being struck by than DCVax-L approval.